Evidose is developing a platform that enables manufacturers of dietary supplements and wellness products to scientifically validate their products' effects through decentralized effectiveness trials. The company handles study design, participant recruitment, test supervision, data analysis, and delivers personalized reports using advanced statistical algorithms that compare supplements against placebos while accounting for demographics and lifestyle. Evidose integrates objective data from wearables (Apple Watch, Fitbit, Whoop, Oura Ring), blood tests, and home cognitive tests to gather outcomes. Co-founded in 2023 by CEO Anna Litwińska and COO Kacper Zambrzycki, the startup is currently running pilots with its first Polish customers. It plans to expand its offering to functional foods, cosmetics, and wellness devices and apps, and aims for a European launch early next year starting with the UK, Germany, France, and Benelux. The company raised €455k to further develop the platform, including automation, and to support its expansion efforts.

Total raised

$1M

Funding rounds

1

Latest round

Equity

Latest activity

Nov 2023